Anmeldung erfolgt in Kürze...
Details werden geladen...
Zealthy Expands Online Access to Ozempic Evaluations and Insurance Support for Eligible Patients With Type 2 Diabetes | The Manila Times
New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy, a telehealth platform that connects patients with licensed healthcare providers, announced today the expansion of its online program designed to help eligible adults with type 2 diabetes explore Ozempic treatment options through remote medical evaluations, insurance coordination, prescription management, and ongoing provider support. The program enables qualified patients to complete assessments from home while receiving guidance on medication eligibility, coverage requirements, and treatment management.
Ähnliche Seiten
Zealthy Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support | The Manila Times
https://www.manilatimes.net/2026/06/24/tmt-newswire/globenewswire/zealthy-launches-enhanced-weight-loss-care-platform-with-integrated-zepbound-access-and-insurance-support/2371415Zealthy Expands Insurance Coordination for GLP-1 Weight-Loss Medications | The Manila Times
https://www.manilatimes.net/2026/06/24/tmt-newswire/globenewswire/zealthy-expands-insurance-coordination-for-glp-1-weight-loss-medications/2371492TWL Announces Expanded Online Access to GLP-1 Weight-Loss Care With Insurance and Self-Pay Options | The Manila Times
https://www.manilatimes.net/2026/06/24/tmt-newswire/globenewswire/twl-announces-expanded-online-access-to-glp-1-weight-loss-care-with-insurance-and-self-pay-options/2371522AM Rx Announces Expanded Online Access and Insurance Support for Zepbound | The Manila Times
https://www.manilatimes.net/2026/06/24/tmt-newswire/globenewswire/am-rx-announces-expanded-online-access-and-insurance-support-for-zepbound/2371424TWL Introduces Virtual Tirzepatide Assessment Program for Eligible Weight-Management Patients | The Manila Times
https://www.manilatimes.net/2026/06/25/tmt-newswire/globenewswire/twl-introduces-virtual-tirzepatide-assessment-program-for-eligible-weight-management-patients/2372432